HORIZON EUROPE | FEBRUARY 2022 CALLS

Due to our expertise and extensive knowledge in the regulatory field for innovative therapies and medical device development, Asphalion can provide with a sound value to Consortia planning to apply.

Due to our expertise and extensive knowledge in the regulatory field for innovative therapies and medical device development, Asphalion can provide with a sound value to Consortia planning to apply.
December 14, 2021

At Asphalion we are looking for new opportunities to collaborate in the currently open Horizon Europe calls with deadline on the 1st of February, 2022. Due to our expertise and extensive knowledge in the regulatory field for innovative therapies and medical device development, Asphalion can provide with a sound value to Consortia planning to apply for the following topics:

  • HORIZON-HLTH-2022-DISEASE-06-02-two-stage: “Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs”
  • HORIZON-HLTH-2022-DISEASE-06-04-two-stage: “Development of new effective therapies for rare diseases”
  • HORIZON-HLTH-2022-DISEASE-06-03-two-stage: “Vaccines 2.0 – developing the next generation of vaccines”
  • HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage: “Prevention of obesity throughout the life course”
  • HORIZON-HLTH-2022-STAYHLTH-01-04-two-stage: “Trustworthy artificial intelligence (AI) tools to predict the risk of chronic non-communicable diseases and/or their progression”

We would like to highlight that some of the above-mentioned topics require some sort of regulatory engagement with regulators and that we are experts in this area. In addition, we have an extensive experience in European projects (H2020), as we are involved in 15 different EU-funded projects as regulatory expert partner.

Either if you are planning to apply and you want to add a regulatory partner to your project, or you are interested in knowing more about Asphalion and our expertise, do not hesitate to contact us at: horizon@asphalion.com

 

 

 

Search News & Events

  • Filter by category

Share

Related news and events

The METHYLOMIC project has been kicked off!

The efficiency and cost-effectiveness will also be assessed in great detail, and experts will guide regulatory approval to ensure delivery of the first epigenetic kit personalised treatment of CD.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting